Windtree Interest Expense from 2010 to 2024

WINT Stock  USD 0.53  0.08  13.11%   
Windtree Therapeutics Interest Expense yearly trend continues to be comparatively stable with very little volatility. Interest Expense will likely drop to about 47.5 K in 2024. Interest Expense is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. View All Fundamentals
 
Interest Expense  
First Reported
1996-06-30
Previous Quarter
110 K
Current Value
-51 K
Quarterly Volatility
62.4 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Windtree Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Windtree Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 77.9 K, Interest Expense of 47.5 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 633, Dividend Yield of 0.0 or PTB Ratio of 0.8. Windtree financial statements analysis is a perfect complement when working with Windtree Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Windtree Therapeutics Correlation against competitors.
For more information on how to buy Windtree Stock please use our How to Invest in Windtree Therapeutics guide.

Latest Windtree Therapeutics' Interest Expense Growth Pattern

Below is the plot of the Interest Expense of Windtree Therapeutics over the last few years. It is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. Windtree Therapeutics' Interest Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Windtree Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Interest Expense10 Years Trend
Slightly volatile
   Interest Expense   
       Timeline  

Windtree Interest Expense Regression Statistics

Arithmetic Mean1,192,767
Geometric Mean343,583
Coefficient Of Variation134.38
Mean Deviation1,248,987
Median400,000
Standard Deviation1,602,875
Sample Variance2.6T
Range4.6M
R-Value(0.31)
Mean Square Error2.5T
R-Squared0.09
Significance0.27
Slope(109,423)
Total Sum of Squares36T

Windtree Interest Expense History

202447.5 K
202350 K
202253 K
2021114 K
2020125 K
2019495 K
20181.4 M

About Windtree Therapeutics Financial Statements

Windtree Therapeutics shareholders use historical fundamental indicators, such as Interest Expense, to determine how well the company is positioned to perform in the future. Although Windtree Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Windtree Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Windtree Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Interest Expense50 K47.5 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Windtree Stock Analysis

When running Windtree Therapeutics' price analysis, check to measure Windtree Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Windtree Therapeutics is operating at the current time. Most of Windtree Therapeutics' value examination focuses on studying past and present price action to predict the probability of Windtree Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Windtree Therapeutics' price. Additionally, you may evaluate how the addition of Windtree Therapeutics to your portfolios can decrease your overall portfolio volatility.